A drug discovery company targeting intrinsically disordered proteins, combining biophysical measurement and AI to design small molecules against them.
Peptone Ltd.
Released October 18, 2025
Flow-matching model that predicts protein conformational ensembles across the order-disorder continuum, from folded domains to disordered chains.